We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
In cases, this will involve hybrid procedures, mixing components of both surgical and interventional therapies, giving rise to the hybrid operating room or hybrid cath lab.